Comparison of functional profiles at human recombinant somatostatin sst 2 receptor: simultaneous determination of intracellular Ca 2+ and luciferase expression in CHO‐K1 cells
Somatostatin (somatotropin release inhibiting factor; SRIF) acts via five G protein‐coupled receptors (sst 1 –sst 5 ) that modulate multiple cellular effectors. The aim of this study was to compare two functional effects of the human sst 2 receptor stably expressed in CHO‐K1 cells in a single experi...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2009-01, Vol.142 (1), p.150-160 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Somatostatin (somatotropin release inhibiting factor; SRIF) acts
via
five G protein‐coupled receptors (sst
1
–sst
5
) that modulate multiple cellular effectors. The aim of this study was to compare two functional effects of the human sst
2
receptor stably expressed in CHO‐K1 cells in a single experiment using a duplex assay for intracellular calcium and serum response element (SRE)‐driven luciferase expression.
Intracellular calcium was measured using a fluorometric imaging plate reader II (FLIPR II). SRIF‐14 rapidly and transiently increased intracellular calcium with a pEC
50
of 8.74±0.03 (
n
=52). At 5 h after FLIPR II measurements, luciferase expression was determined. SRIF‐14 concentration‐dependently increased luciferase expression (pEC
50
=9.06±0.03,
n
=52).
Natural and synthetic agonist/antagonist ligands for SRIF receptors were tested in the duplex assay. Correlation of agonist potencies and efficacies between the two responses were significant (
r
2
=0.83 and 0.90, pEC
50
and
E
max
, respectively).
Pertussis toxin pretreatment reduced SRIF‐14/octreotide‐mediated intracellular calcium increases by 45–47% and luciferase expression by 95–98%.
Thapsigargin pretreatment abolished the SRIF‐14/octreotide‐mediated intracellular calcium increase but had no effect on luciferase expression.
In conclusion, SRIF stimulates an increase in intracellular calcium and SRE‐luciferase expression
via
human sst
2
receptors in CHO‐K1 cells. The increase in luciferase is mediated
via
G
i
/G
o
while intracellular calcium increase is mediated by both G
i
/G
o
proteins and pertussis toxin‐insensitive G proteins, and is mainly
via
release of calcium from intracellular stores. SRIF ligands display a similar recognition profile suggesting that the ligand/receptor/G protein/effector interaction is similar for the two parameters.
British Journal of Pharmacology
(2004)
142
, 150–160. doi:
10.1038/sj.bjp.0705735 |
---|---|
ISSN: | 0007-1188 1476-5381 |
DOI: | 10.1038/sj.bjp.0705735 |